Interestingly, a recent study indicated that the majority of invasive breast cancers (67%, n = 133) showed a nuclear immunoreactivity of the estrogen-inducible FOXP151, whereby knockdown of FOXP1 suppressed and ectopic expression promoted breast cancer cell proliferation. Here, FOXP1 is linked to breast carcinoma.